|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 162.6 USD | -0.11% |
|
-0.06% | +4.89% |
| Apr. 30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
| Apr. 29 | Health Care Up on Growth Optimism -- Health Care Roundup | DJ |
AbbVie Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 12,310 million compared to USD 12,225 million a year ago. Net income was USD 1,369 million compared to USD 239 million a year ago.
Diluted earnings per share from continuing operations was USD 0.77 compared to USD 0.13 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +4.89% | 287B | |
| +33.43% | 690B | |
| +26.43% | 546B | |
| -5.12% | 358B | |
| +19.59% | 323B | |
| +14.32% | 235B | |
| +5.79% | 199B | |
| -9.49% | 195B | |
| +4.26% | 161B | |
| -3.54% | 159B |
ABBVIE INC. 
